{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:03:34Z","timestamp":1780326214520,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01828-3","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T01:26:35Z","timestamp":1780277195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of a novel dual-target modulator of ULK1 and ERK1\/2 that suppresses triple-negative breast cancer progression and metastasis via the Exo70\/Cav-1\/MMPs axis"],"prefix":"10.1038","author":[{"given":"Min-ru","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-chao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-qiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-yu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7572-1035","authenticated-orcid":false,"given":"Lan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3900-9486","authenticated-orcid":false,"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"1828_CR1","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1021\/acs.jmedchem.0c01180","volume":"64","author":"M Liao","year":"2021","unstructured":"Liao M, Zhang J, Wang G, Wang L, Liu J, Ouyang L, et al. Small-molecule drug discovery in triple negative breast cancer: Current situation and future directions. J Med Chem. 2021;64:2382\u2013418.","journal-title":"J Med Chem"},{"key":"1828_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan F, Reis-Filho JS. Pathogenesis of triple-negative breast cancer. Annu Rev Pathol. 2022;17:181\u2013204.","journal-title":"Annu Rev Pathol"},{"key":"1828_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang H, Merkher Y, Chen L, Liu N, Leonov S, et al. Recent advances in therapeutic strategies for triple-negative breast cancer. J Hematol Oncol. 2022;15:121.","journal-title":"J Hematol Oncol"},{"key":"1828_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini G, De Angelis C, Licata L, Gianni L. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs. Nat Rev Clin Oncol. 2022;19:91\u2013113.","journal-title":"Nat Rev Clin Oncol"},{"key":"1828_CR5","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1158\/2159-8290.CD-22-0200","volume":"12","author":"M Anurag","year":"2022","unstructured":"Anurag M, Jaehnig EJ, Krug K, Lei JT, Bergstrom EJ, Kim BJ, et al. Proteogenomic markers of chemotherapy resistance and response in triple-negative breast cancer. Cancer Discov. 2022;12:2586\u2013605.","journal-title":"Cancer Discov"},{"key":"1828_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.semcancer.2020.06.005","volume":"72","author":"F Borri","year":"2021","unstructured":"Borri F, Granaglia A. Pathology of triple negative breast cancer. Semin Cancer Biol. 2021;72:136\u201345.","journal-title":"Semin Cancer Biol"},{"key":"1828_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202500722","volume":"12","author":"J Xie","year":"2025","unstructured":"Xie J, Liu W, Deng X, Wang H, Ou X, An X, et al. Paracrine orchestration of tumor microenvironment remodeling induced by Glo1 potentiates lymph node metastasis in breast cancer. Adv Sci. 2025;12:e00722.","journal-title":"Adv Sci"},{"key":"1828_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.502","volume":"5","author":"J Xie","year":"2024","unstructured":"Xie J, Deng X, Xie Y, Zhu H, Liu P, Deng W, et al. Multi-omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple-negative breast cancer. MedComm. 2024;5:e502.","journal-title":"MedComm"},{"key":"1828_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/15548627.2022.2062112","volume":"19","author":"Y Xu","year":"2023","unstructured":"Xu Y, Wan W. Acetylation in the regulation of autophagy. Autophagy. 2023;19:379\u201387.","journal-title":"Autophagy"},{"key":"1828_CR10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/15548627.2017.1283470","volume":"13","author":"L Ouyang","year":"2017","unstructured":"Ouyang L, Zhang L, Fu L, Liu B. A small-molecule activator induces ULK1-modulating autophagy-associated cell death in triple negative breast cancer. Autophagy. 2017;13:777\u20138.","journal-title":"Autophagy"},{"key":"1828_CR11","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1039\/C6SC05368H","volume":"8","author":"L Zhang","year":"2017","unstructured":"Zhang L, Fu L, Zhang S, Zhang J, Zhao Y, Zheng Y, et al. Discovery of a small molecule targeting ULK1-modulated cell death of triple-negative breast cancer in vitro and in vivo. Chem Sci. 2017;8:2687\u2013701.","journal-title":"Chem Sci"},{"key":"1828_CR12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/s41388-024-02950-4","volume":"43","author":"H Song","year":"2024","unstructured":"Song H, Zhao Z, Ma L, Zhao W, Hu Y, Song Y. Novel exosomal cirCegfr facilitates triple negative breast cancer autophagy via promoting TFEB nuclear trafficking and modulating mir-224-5p\/ATG13\/ULK1 feedback loop. Oncogene. 2024;43:821\u201336.","journal-title":"Oncogene"},{"key":"1828_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03266-9","volume":"24","author":"M Zhao","year":"2024","unstructured":"Zhao M, Xu P, Shi W, Wang J, Wang T, Li P. ICARIIN exerts anti-tumor activity by inducing autophagy via AMPK\/mTOR\/ULK1 pathway in triple-negative breast cancer. Cancer Cell Int. 2024;24:74.","journal-title":"Cancer Cell Int"},{"key":"1828_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2024.168472","volume":"436","author":"G Pareek","year":"2024","unstructured":"Pareek G, Kundu M. Physiological functions of ULK1\/2. J Mol Biol. 2024;436:168472.","journal-title":"J Mol Biol"},{"key":"1828_CR15","doi-asserted-by":"crossref","unstructured":"Bal Albayrak MG, Yanar S, Korak T, Akpinar G, Kasap M. Ulk1-driven autophagy modulation alters tumor-promoting pathways in triple-negative breast cancer. Medical oncology. Northwood, London, England. 2026;43.","DOI":"10.1007\/s12032-026-03274-x"},{"key":"1828_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156068","volume":"135","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liu P, Jin Y, Zhu H, Wang M, Jiang X, et al. A combined treatment with ursolic acid and solasodine inhibits colorectal cancer progression through the Akt1\/ERK1\/2-GSK-3\u03b2-\u03b2-catenin axis. Phytomedicine. 2024;135:156068.","journal-title":"Phytomedicine"},{"key":"1828_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175515","volume":"942","author":"Y Yang","year":"2023","unstructured":"Yang Y, Jin Y, Yin L, Liu P, Zhu L, Gao H. Sertaconazole nitrate targets ido1 and regulates the MAPK signaling pathway to induce autophagy and apoptosis in CRC cells. Eur J Pharmacol. 2023;942:175515.","journal-title":"Eur J Pharmacol"},{"key":"1828_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155746","volume":"130","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wei S, Zhang Q, Zhang Y, Sun C. Paris saponin VII inhibits triple-negative breast cancer by targeting the MEK\/ERK\/STMN1 signaling axis. Phytomedicine. 2024;130:155746.","journal-title":"Phytomedicine"},{"key":"1828_CR19","doi-asserted-by":"publisher","first-page":"116985","DOI":"10.1016\/j.biopha.2024.116985","volume":"177","author":"J Zhang","year":"2024","unstructured":"Zhang J, Teng F, Wu T, Li S, Li K. Quercetin inhibits chronic stress-mediated progression of triple-negative breast cancer by blocking \u03b22-AR\/ERK1\/2 pathway. Biomed Pharmacother. 2024;177:116985.","journal-title":"Biomed Pharmacother"},{"key":"1828_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.freeradbiomed.2025.10.003","volume":"241","author":"R Tian","year":"2025","unstructured":"Tian R, Li D, Lan C, Xu H, Ma X, Chen D, et al. Targeting the PRSS3-PAR2-ERK1\/2 axis inhibits malignancy and regulates chemosensitivity and resistance through ferroptosis in breast cancer. Free Radic Biol Med. 2025;241:642\u201358.","journal-title":"Free Radic Biol Med"},{"key":"1828_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13923-7","volume":"11","author":"L Mao","year":"2020","unstructured":"Mao L, Zhan YY, Wu B, Yu Q, Xu L, Hong X, et al. Ulk1 phosphorylates Exo70 to suppress breast cancer metastasis. Nat Commun. 2020;11:117.","journal-title":"Nat Commun"},{"key":"1828_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202310065","volume":"11","author":"S Ma","year":"2024","unstructured":"Ma S, Wu Q, Wu W, Tian Y, Zhang J, Chen C, et al. Urolithin a hijacks ERK1\/2-ULK1 cascade to improve CD8+ T cell fitness for antitumor immunity. Adv Sci (Weinh). 2024;11:e2310065.","journal-title":"Adv Sci (Weinh)"},{"key":"1828_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41392-024-01816-1","volume":"9","author":"P Fu","year":"2024","unstructured":"Fu P, Minru L, Wenke J, Wei L, Zixiang L, Zhichao F, et al. 2-Apqc, a small-molecule activator of sirtuin-3 (Sirt3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis. Signal Transduct Target Ther. 2024;9:133.","journal-title":"Signal Transduct Target Ther"},{"key":"1828_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106077","volume":"176","author":"M Liao","year":"2022","unstructured":"Liao M, Xie Q, Zhao Y, Yang C, Lin C, Wang G, et al. Main active components of si-miao-yong-an decoction (SMYAD) attenuate autophagy and apoptosis via the PDE5a-Akt and TLR4-Nox4 pathways in isoproterenol (Iso)-induced heart failure models. Pharmacol Res. 2022;176:106077.","journal-title":"Pharmacol Res"},{"key":"1828_CR25","doi-asserted-by":"publisher","first-page":"15121","DOI":"10.3390\/ijms242015121","volume":"24","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Liao M, Li Z, Ye J, Wu L, Mou Y, et al. Flubendazole enhances the inhibitory effect of paclitaxel via HIF1\u03b1\/PI3K\/Akt signaling pathways in breast cancer. Int J Mol Sci. 2023;24:15121.","journal-title":"Int J Mol Sci"},{"key":"1828_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/science.adk0850","volume":"384","author":"JE Klomp","year":"2024","unstructured":"Klomp JE, Diehl JN, Klomp JA, Edwards AC, Yang R, Morales AJ, et al. Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer. Science. 2024;384:eadk0850.","journal-title":"Science"},{"key":"1828_CR27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","volume":"21","author":"H Lavoie","year":"2020","unstructured":"Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol. 2020;21:607\u201332.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1828_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/cancers16020336","volume":"16","author":"J Xiang","year":"2024","unstructured":"Xiang J, Zheng B, Zhao L, He Y, Lou F, Li R, et al. Exo70 promotes the invasion of pancreatic cancer cells via the regulation of exosomes. Cancers. 2024;16:336.","journal-title":"Cancers"},{"key":"1828_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/21541248.2017.1328998","volume":"10","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Wu B, Guo W. The role of Exo70 in exocytosis and beyond. Small GTPases. 2019;10:331\u20135.","journal-title":"Small GTPases"},{"key":"1828_CR30","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.3390\/cancers13143467","volume":"13","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Hong X, Chen X, Hu C, Lu W, Xie B, et al. Deregulation of Exo70 facilitates innate and acquired cisplatin resistance in epithelial ovarian cancer by promoting cisplatin efflux. Cancers. 2021;13:3467.","journal-title":"Cancers"},{"key":"1828_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05308-x","volume":"7","author":"L Xiao","year":"2017","unstructured":"Xiao L, Zheng K, Lv X, Hou J, Xu L, Zhao Y, et al. Exo70 is an independent prognostic factor in colon cancer. Sci Rep. 2017;7:5039.","journal-title":"Sci Rep"},{"key":"1828_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114604","volume":"43","author":"J Hou","year":"2024","unstructured":"Hou J, Mei K, Wang D, Ke S, Chen X, Shang J, et al. TGM1\/3-mediated transamidation of Exo70 promotes tumor metastasis upon LKB1 inactivation. Cell Rep. 2024;43:114604.","journal-title":"Cell Rep"},{"key":"1828_CR33","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","volume":"14","author":"M Liao","year":"2024","unstructured":"Liao M, Yao D, Wu L, Luo C, Wang Z, Zhang J, et al. Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer. Acta Pharm Sin B. 2024;14:953\u20131008.","journal-title":"Acta Pharm Sin B"},{"key":"1828_CR34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41401-022-00972-w","volume":"44","author":"W Liu","year":"2023","unstructured":"Liu W, Zhu SO, Guo YL, Tu LF, Zhen YQ, Zhao RY, et al. Bl-918, a small-molecule activator of ULK1, induces cytoprotective autophagy for amyotrophic lateral sclerosis therapy. Acta Pharmacol Sin. 2023;44:524\u201337.","journal-title":"Acta Pharmacol Sin"},{"key":"1828_CR35","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41401-023-01164-w","volume":"45","author":"CY Chiang","year":"2024","unstructured":"Chiang CY, Zhang M, Huang J, Zeng J, Chen C, Pan D, et al. A novel selective ERK1\/2 inhibitor, laxiflorin b, targets EGFR mutation subtypes in non-small-cell lung cancer. Acta Pharmacol Sin. 2024;45:422\u201335.","journal-title":"Acta Pharmacol Sin"},{"key":"1828_CR36","doi-asserted-by":"publisher","first-page":"0747","DOI":"10.34133\/research.0747","volume":"8","author":"S Baldi","year":"2025","unstructured":"Baldi S, Long N, Ma S, Liu L, Al-Danakh A, Yang Q, et al. Advancements in protein kinase inhibitors: From discovery to clinical applications. Research. 2025;8:0747.","journal-title":"Research"},{"key":"1828_CR37","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1515\/med-2021-0341","volume":"16","author":"W Yu","year":"2021","unstructured":"Yu W, Ke X, Li M, Ye P, Peng J, Li H. Downregulation of Rab7 and caveolin-1 increases MMP-2 activity in renal tubular epithelial cells under hypoxic conditions. Open Med. 2021;16:1428\u201337.","journal-title":"Open Med"},{"key":"1828_CR38","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/aps.2018.27","volume":"39","author":"HS Chen","year":"2018","unstructured":"Chen HS, Chen X, Li WT, Shen JG. Targeting RNS\/caveolin-1\/mmp signaling cascades to protect against cerebral ischemia-reperfusion injuries: potential application for drug discovery. Acta Pharmacol Sin. 2018;39:669\u201382.","journal-title":"Acta Pharmacol Sin"},{"key":"1828_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155071","volume":"120","author":"X Sun","year":"2023","unstructured":"Sun X, Liu Z, Zhou L, Ma R, Zhang X, Wang T, et al. Escin avoids hemorrhagic transformation in ischemic stroke by protecting the BBB through the AMPK\/Cav-1\/MMP-9 pathway. Phytomedicine. 2023;120:155071.","journal-title":"Phytomedicine"},{"key":"1828_CR40","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/jnc.13065","volume":"132","author":"X Jin","year":"2015","unstructured":"Jin X, Sun Y, Xu J, Liu W. Caveolin-1 mediates tissue plasminogen activator-induced MMP-9 up-regulation in cultured brain microvascular endothelial cells. J Neurochem. 2015;132:724\u201330.","journal-title":"J Neurochem"},{"key":"1828_CR41","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.2147\/IJN.S444009","volume":"19","author":"Y Li","year":"2024","unstructured":"Li Y, Chen J, Quan X, Chen Y, Han Y, Chen J, et al. Extracellular vesicles maintain blood-brain barrier integrity by the suppression of caveolin-1\/CD147\/VEGFR2\/MMP pathway after ischemic stroke. Int J Nanomed. 2024;19:1451\u201367.","journal-title":"Int J Nanomed"},{"key":"1828_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155553","volume":"130","author":"M Qin","year":"2024","unstructured":"Qin M, Ou R, He W, Han H, Zhang Y, Huang Y, et al. Salvianolic acid B enhances tissue repair and regeneration by regulating immune cell migration and caveolin-1-mediated blastema formation in zebrafish. Phytomedicine. 2024;130:155553.","journal-title":"Phytomedicine"},{"key":"1828_CR43","doi-asserted-by":"publisher","first-page":"11112","DOI":"10.1074\/jbc.M312947200","volume":"279","author":"W Tang","year":"2004","unstructured":"Tang W, Hemler ME. Caveolin-1 regulates matrix metalloproteinases-1 induction and CD147\/emmprin cell surface clustering. J Biol Chem. 2004;279:11112\u20138.","journal-title":"J Biol Chem"},{"key":"1828_CR44","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s11064-025-04458-z","volume":"50","author":"X Li","year":"2025","unstructured":"Li X, Ding W, Zhang X, Tang X, Zheng Y, Ma Y, et al. Caveolin-1-mediated blood-brain barrier disruption via MMP2\/9 contributes to postoperative cognitive dysfunction. Neurochem Res. 2025;50:210.","journal-title":"Neurochem Res"},{"key":"1828_CR45","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuroscience.2018.02.035","volume":"377","author":"S Zhang","year":"2018","unstructured":"Zhang S, An Q, Wang T, Gao S, Zhou G. Autophagy- and MMP-2\/9-mediated reduction and redistribution of ZO-1 contribute to hyperglycemia-increased blood-brain barrier permeability during early reperfusion in stroke. Neuroscience. 2018;377:126\u201337.","journal-title":"Neuroscience"},{"key":"1828_CR46","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.prp.2014.04.010","volume":"210","author":"F Han","year":"2014","unstructured":"Han F, Zhang J, Shao J, Yi X. Caveolin-1 promotes an invasive phenotype and predicts poor prognosis in large cell lung carcinoma. Pathol, Res Pract. 2014;210:514\u201320.","journal-title":"Pathol, Res Pract"},{"key":"1828_CR47","doi-asserted-by":"publisher","first-page":"51630","DOI":"10.1074\/jbc.M409214200","volume":"279","author":"TM Williams","year":"2004","unstructured":"Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, et al. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2\/9) secretion. J Biol Chem. 2004;279:51630\u201346.","journal-title":"J Biol Chem"},{"key":"1828_CR48","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1096\/fj.11-188607","volume":"25","author":"W Huang","year":"2011","unstructured":"Huang W, Andr\u00e1s IE, Rha GB, Hennig B, Toborek M. PPAR\u03b1 and PPAR\u03b3 protect against HIV-1-induced MMP-9 overexpression via caveolae-associated ERK and AKT signaling. FASEB J. 2011;25:3979\u201388.","journal-title":"FASEB J"},{"key":"1828_CR49","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s12032-011-9900-5","volume":"29","author":"Y Tang","year":"2012","unstructured":"Tang Y, Zeng X, He F, Liao Y, Qian N, Toi M. Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer. Med Oncol. 2012;29:977\u201384.","journal-title":"Med Oncol"},{"key":"1828_CR50","doi-asserted-by":"publisher","first-page":"8594","DOI":"10.1158\/0008-5472.CAN-09-2305","volume":"69","author":"H Yamaguchi","year":"2009","unstructured":"Yamaguchi H, Takeo Y, Yoshida S, Kouchi Z, Nakamura Y, Fukami K. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells. Cancer Res. 2009;69:8594\u2013602.","journal-title":"Cancer Res"},{"key":"1828_CR51","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1111\/jcmm.15076","volume":"24","author":"W Pu","year":"2020","unstructured":"Pu W, Qiu J, Nassar ZD, Shaw PN, McMahon KA, Ferguson C, et al. A role for caveola-forming proteins Caveolin-1 and Cavin1 in the pro-invasive response of glioblastoma to osmotic and hydrostatic pressure. J Cell Mol Med. 2020;24:3724\u201338.","journal-title":"J Cell Mol Med"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01828-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01828-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01828-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:03:46Z","timestamp":1780322626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01828-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":51,"alternative-id":["1828"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01828-3","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}